|
Natarajan, Karthika; Xie, Yi; Baer, Maria R et al. (2012) Role of breast cancer resistance protein (BCRP/ABCG2) in cancer drug resistance. Biochem Pharmacol 83:1084-103
|
|
Bauer, Kenneth S; Karp, Judith E; Garimella, Tushar S et al. (2005) A phase I and pharmacologic study of idarubicin, cytarabine, etoposide, and the multidrug resistance protein (MDR1/Pgp) inhibitor PSC-833 in patients with refractory leukemia. Leuk Res 29:263-71
|
|
Ross, D D; Karp, J E; Chen, T T et al. (2000) Expression of breast cancer resistance protein in blast cells from patients with acute leukemia. Blood 96:365-8
|
|
Ross, D D; Yang, W; Abruzzo, L V et al. (1999) Atypical multidrug resistance: breast cancer resistance protein messenger RNA expression in mitoxantrone-selected cell lines. J Natl Cancer Inst 91:429-33
|
|
Doyle, L A; Yang, W; Abruzzo, L V et al. (1998) A multidrug resistance transporter from human MCF-7 breast cancer cells. Proc Natl Acad Sci U S A 95:15665-70
|
|
Ross, D D; Gao, Y; Yang, W et al. (1997) The 95-kilodalton membrane glycoprotein overexpressed in novel multidrug-resistant breast cancer cells is NCA, the nonspecific cross-reacting antigen of carcinoembryonic antigen. Cancer Res 57:5460-4
|
|
Doyle, L A; Yang, W; Rishi, A K et al. (1996) H19 gene overexpression in atypical multidrug-resistant cells associated with expression of a 95-kilodalton membrane glycoprotein. Cancer Res 56:2904-7
|
|
Ross, D D; Doyle, L A; Yang, W et al. (1995) Susceptibility of idarubicin, daunorubicin, and their C-13 alcohol metabolites to transport-mediated multidrug resistance. Biochem Pharmacol 50:1673-83
|
|
Doyle, L A; Ross, D D; Sridhara, R et al. (1995) Expression of a 95 kDa membrane protein is associated with low daunorubicin accumulation in leukaemic blast cells. Br J Cancer 71:52-8
|
|
Doyle, L A (1994) Topoisomerase expression in cancer cell lines and clinical samples. Cancer Chemother Pharmacol 34 Suppl:S32-40
|
Showing the most recent 10 out of 12 publications
